# Synera Venipuncture Pain

> **NCT01744197** · PHASE2 · COMPLETED · sponsor: **US Oncology Research** · enrollment: 61 (actual)

## Conditions studied

- Pain
- Phlebotomy
- Palliative Care

## Interventions

- **DRUG:** Synera (lidocaine 70mg/tetracaine 70mg)

## Key facts

- **NCT ID:** NCT01744197
- **Lead sponsor:** US Oncology Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-11
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744197, "Synera Venipuncture Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01744197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*